About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Philadelphia | 362 Studies

Clinical Trials Prostate CancerPhiladelphia

Prostate Cancer Clinical Trials in Philadelphia

Find 362 clinical trials for prostate cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 362 trials

RecruitingOpen-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyThis is a Phase II/III study.NCT06780670·Scottsdale, Arizona and 92 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone…NCT06991556·La Jolla, California and 65 others

Active not recruitingCART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate CancerThis is a single center, single arm Phase I study to establish the safety and feasibility of intravenously administered lentivirally transduced dual PSMA-specific/TGFβ-resistant…NCT03089203·Philadelphia, Pennsylvania

UnknownCommunication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their PartnersRATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners.NCT00503646·New York, New York and 1 other

CompletedBrachytherapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy through seeds implanted into the prostate may kill more tumor cells.NCT00003312·Birmingham, Alabama and 257 others

TerminatedA Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate CarcinomaThis is a phase 1, open-label study evaluating the safety, clinical pharmacology and clinical activity of AMG 340, a PSMA x CD3 T-cell engaging bispecific antibody, in subjects…NCT04740034·San Francisco, California and 6 others

TerminatedMRI Guided Radiation Therapy for the Treatment of High Risk Prostate CancerThis phase II trial tests whether magnetic resonance imaging (MRI)-guided hypofractionated radiation therapy works to reduce treatment time and side effects in patients with high…NCT05676463·Philadelphia, Pennsylvania

CompletedCabazitaxel With Radiation and Hormone Therapy for Prostate CancerThis is a single-center, open-label, non-randomized Phase I study of weekly Cabazitaxel with concurrent intensity modulated radiation therapy (IMRT) (A type of 3-dimensional…NCT01420250·Philadelphia, Pennsylvania

CompletedDolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003626·Denver, Colorado and 2 others

TerminatedAssessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to TherapyThe study is an open label, non-randomized study designed to evaluate the diagnostic performance of SPECT CT.NCT03619655·Baltimore, Maryland and 1 other

CompletedA Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal MetastasesALSYMPCA (ALpharadin in SYMPtomatic Prostate CAncer) is an international Phase III clinical study to evaluate the efficacy and safety of Radium-223 dichloride in patients with…NCT00699751·Los Angeles, California and 133 others

CompletedFunctional MRI Use in Prostate Radiation Treatment PlanningThis study is being done to evaluate the use of MRI during radiation treatment planning to identify areas of tumor within the prostate to aid in future treatment planning and…NCT01985932·Philadelphia, Pennsylvania

CompletedA Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)The goal of this clinical trial is to test the safety and efficacy of KVA12123 alone or combined with pembrolizumab in patients with advanced solid tumors.NCT05708950·Santa Monica, California and 6 others

CompletedPhase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast CancerThe purpose of this first multi-dose study in cancer patients is to determine the maximum tolerated dose (MTD) or recommended phase II dose (RP2D), characterize the safety…NCT01338831·Boston, Massachusetts and 8 others

CompletedImmunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)This is an open label, Phase 2 trial of APC8015F immunotherapy in men with objective disease progression on protocol D9902 part B (NCT00065442)NCT00849290·Los Angeles, California and 57 others

CompletedA Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate CancerThe purpose of this study is to determine the benefit of enzalutamide versus placebo as assessed by overall survival and progression-free survival in patients with progressive…NCT01212991·Birmingham, Alabama and 268 others

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

CompletedAnalyses of Human Samples Collected in Clinical TrialsCancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes.NCT00339664·Washington D.C., District of Columbia and 16 others

TerminatedA Study of CART-PSMA-TGFβRDN in Patients With Metastatic Castration Resistant Prostate CancerMulti-center, open-label, Phase 1 study of the safety, tolerability and feasibility of dosing patients harboring metastatic castration resistant prostate cancer (mCRPC) with…NCT04227275·Tampa, Florida and 8 others

PreviousPage 7 of 19Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma